Current status: 1071 hESC lines, 6956 hiPSC lines, and 178 clinical studies, and 2393 certificates
Monthly statistic from Apr 1, 2025
Posted on April 1, 2025
total lines | 8027 |
hESC lines | 1071 |
hiPSC lines | 6956 |
derivation countries | 50 |
projects | 317 |
providers | 976 |
clinical studies | 178 |
subclones | 3441 |
certificates | 2393 |
cell line certificates | 2245 |
project certificates | 148 |